Tag: Olivier Cussenot
Irreversible electroporation: A safe and effective therapy for low to intermediary prostate cancer risk profiles
Prostate cancer affects millions of men globally, and is also the third-largest cause of cancer-related deaths among men. Irreversible electroporation (IRE) is one of the more targeted, focal, and minimally aggressive therapies for prostate cancer ablation in comparison to radiotherapy, thermal, or cryo-based ablation methods. Distinguished scientist Professor Olivier Cussenot, surgeon urologist expert for the French National Cancer Institute, is […]